The head of the research based pharmaceutical industry, Stephen Whitehead, will today say to company leaders that the UK must prioritise patient access to life-saving medicines, and ensure proper funding for the development of new, innovative treatments, or run the risk of failing to meet the demands of tackling diseases in the future. Read more